SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (65)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sacco, K. A.
Right arrow Articles by George, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sacco, K. A.
Right arrow Articles by George, T. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders

Kristi A. Sacco

Program for Research in Smokers with Mental Illness (PRISM), Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA, kristi.sacco{at}yale.edu

Katie L. Bannon

Program for Research in Smokers with Mental Illness (PRISM), Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA

Tony P. George

Program for Research in Smokers with Mental Illness (PRISM), Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA

Cigarette smoking rates in the American population are approximately 23%, whereas rates of smoking in clinical and population studies of individuals with neuropsychiatric disorders are typically two- to four-fold higher. Studies conducted in a variety of neuropsychiatric populations [e.g. attention-deficit hyperactivity disorder (ADHD), Alzheimer’s disease, schizophrenia] have collectively suggested that nicotine may be efficacious in remediating selected cognitive deficits associated with these disorders, thus providing a framework for understanding the specific vulnerability of these patients to smoking initiation and maintenance. However, the specific gain in cognitive performance produced by nicotine administration in healthy subjects with normal cognitive function is less clear. This article reviews our current understanding of central nicotinic acetylcholine receptor (nAChRs) systems in normal and neuropsychiatric disease states and, specifically, their role with respect to cognitive dysfunction and clinical symptoms in several specific neuropsychiatric populations, including ADHD, Alzheimer’s disease, Parkinson’s disease, Tourette’s Disorder, schizophrenia and affective disorders. The potential benefits of nicotinic agents for therapeutic use in neuropsychiatric disorders is discussed, as well as directions for further research in this area.

Key Words: attention • cigarette smoking • cognitive function • executive function • nicotinic receptor • neuropsychiatric disorder • working memory

Journal of Psychopharmacology, Vol. 18, No. 4, 457-474 (2004)
DOI: 10.1177/0269881104047273


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Nicotine Tob ResHome page
L. F. Martin, D. B. Davalos, and M. A. Kisley
Nicotine enhances automatic temporal processing as measured by the mismatch negativity waveform
Nicotine Tob Res, June 1, 2009; 11(6): 698 - 706.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
G. Winterer, F. Musso, A. Konrad, G. Vucurevic, P. Stoeter, T. Sander, and J. Gallinat
Association of attentional network function with exon 5 variations of the CHRNA4 gene
Hum. Mol. Genet., September 15, 2007; 16(18): 2165 - 2174.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Besson, S. Granon, M. Mameli-Engvall, I. Cloez-Tayarani, N. Maubourguet, A. Cormier, P. Cazala, V. David, J.-P. Changeux, and P. Faure
Long-term effects of chronic nicotine exposure on brain nicotinic receptors
PNAS, May 8, 2007; 104(19): 8155 - 8160.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
T. C. Durazzo, S. Gazdzinski, and D. J. Meyerhoff
The neurobiological and neurocognitive consequences of chronic cigarette smoking in alcohol use disorders
Alcohol Alcohol., May 1, 2007; 42(3): 174 - 185.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
A. C. Chess, M. K. Simoni, T. E. Alling, and D. J. Bucci
Elevations of Endogenous Kynurenic Acid Produce Spatial Working Memory Deficits
Schizophr Bull, May 1, 2007; 33(3): 797 - 804.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
J.-P. Changeux
The Ferrier Lecture 1998 The molecular biology of consciousness investigated with genetically modified mice
Phil Trans R Soc B, December 29, 2006; 361(1476): 2239 - 2259.
[Abstract] [Full Text] [PDF]



Advertisement